References
- Lu LX, Della-Torre E, Stone JH, Clark SW. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. JAMA Neurol 2014;71:785-793. https://doi.org/10.1001/jamaneurol.2014.243
- Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012;22:21-30. https://doi.org/10.3109/s10165-011-0571-z
- Takeuchi S, Osada H, Seno S, Nawashiro H. IgG4-related intracranial hypertrophic pachymeningitis: a case report and review of the literature. J Korean Neurosurg Soc 2014;55:300-302. https://doi.org/10.3340/jkns.2014.55.5.300
- Joshi D, Jager R, Hurel S, Pereira SP, Johnson GJ, Chapman M, et al. Cerebral involvement in IgG4-related diseases. Clin Med (Lond) 2015;15:130-134. https://doi.org/10.7861/clinmedicine.15-2-130
- Bosman T, Simonin C, Launay D, Caron S, Destee A, Defebvre L. Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature. Rheumatol Int 2008;28:713-718. https://doi.org/10.1007/s00296-007-0504-5
- Lee HJ, Yoon BA, Ryu WY, Kim JK. An idiopathic hypertrophic tentorial pachymeningitis presented as an alternating recurrent painful ophthalmoplegia. J Korean Neurol Assoc 2016;34:239-242. https://doi.org/10.17340/jkna.2016.3.15
- Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 2015;67:1688-1699. https://doi.org/10.1002/art.39132